Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 1-10 of 12

Page
per page
  1. (R)-CCG-1423
    C5799 (R)-CCG-1423
    Summary: Rho inhibitor
      ≤0.25 mg/mL
  2. (S)-CCG-1423
    C5803 (S)-CCG-1423
    Summary: Rho inhibitor
      ≤0.25 mg/mL
  3. SB 772077B dihydrochloride
    B5529 SB 772077B dihydrochloride
    Summary: Rho-kinase (ROCK) inhibitor
      <41.53 mg/mL
  4. AS 1892802
    B5773 AS 1892802
    Summary: ROCK inhibitor,potent and ATP-competitive
      Soluble in DMSO
  5. 6H05
    A8902 6H05
    Summary: K-Ras inhibitor
      ≥29.5 mg/mL
  6. K-115
    B4809 K-115
    Summary: Selective Rho kinase inhibitor
      insoluble in EtOH; ≥123.2 mg/mL
  7. CCG-1423
    B4897 CCG-1423
    Target: Rho
    Summary: RhoA inhibitor
      ≥21 mg/mL
  8. K-Ras(G12C) inhibitor 6
    B3694 K-Ras(G12C) inhibitor 6
    Target: KRAS G12C
    Summary: K-Ras (G12C) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥20.25 mg/mL
  9. Zoledronic Acid
    A1352 Zoledronic Acid
    Target: Farnesyl Diphosphate Synthases
    Summary: Potent nitrogen-containing bisphosphonates
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  10. NSC23766 trihydrochloride
    A1952 NSC23766 trihydrochloride
    Summary: Selective inhibitor of Rac1-GEF interaction.
      ≥26.55 mg/mL

Items 1-10 of 12

Page
per page